Showing 692 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

New nanotechnique to deliver life-saving drugs to the brain

Editor's pick
Phys.org
22 April 2013
Generic medicines

Preparing for Generics: The push for affordable HIV treatment doesn’t end with patent expirations

Editor's pick
Treatment Action Group
11 April 2013
New & experimental HIV treatments

DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
DFH Pharma press release
4 April 2013
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
22 March 2013
Weight gain & lipodystrophy

Health Canada rejects tesamorelin for lipodystrophy

Editor's pick
Theratechnologies press release
13 March 2013
Vaginal rings & topical PrEP

Bee Venom Destroys HIV And Spares Surrounding Cells

Editor's pick
HIV / AIDS News From Medical News Today
10 March 2013
Finance & funding

Funding Scientific Innovation: Global Investments in HIV Treatment Research and Development in 2010 and 2011

Editor's pick
Treatment Action Group
7 March 2013
Pharmaceutical industry

GSK wins priority status for new HIV drug in US

Editor's pick
Reuters
18 February 2013
How HIV works

Newly identified natural protein blocks HIV, other deadly viruses

Editor's pick
UCLA press release
12 February 2013
New & experimental HIV treatments

ViiV announces halt to lersivirine development

Editor's pick
HIVandHepatitis.com
7 February 2013
New & experimental HIV treatments

Innovative HIV Gene Therapy Study Soon to Start Enrollment

Editor's pick
TheBody.com
6 February 2013
New & experimental HIV treatments

Suboptimal Suppression with Maraviroc plus a Boosted Protease Inhibitor?

Editor's pick
Journal Watch
5 February 2013
New & experimental HIV treatments

Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV

Editor's pick
Gilead press release
25 January 2013
Pharmaceutical industry

Gilead petitions FDA over its Stribild AIDS med

Editor's pick
Pharmalot
25 January 2013
The search for a cure

Pitt team finds 'Achilles Heel' of key HIV replication protein

Editor's pick
Eurekalert (press release)
25 January 2013
The search for a cure

Stanford lab creates HIV-resistant cells

Editor's pick
San Francisco Chronicle
23 January 2013
New & experimental HIV treatments

Researchers attack HIV's final defenses before drug-resistant mutations emerge

Editor's pick
Medical Xpress
17 January 2013
The search for an HIV prevention vaccine

New insights into HIV vaccine will improve drug development

Editor's pick
Science Daily
11 January 2013
Side effects

FDA clears Salix anti-diarrhoeal for HIV patients

Editor's pick
MarketWatch
2 January 2013
New & experimental HIV treatments

ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir

Editor's pick
AIDSMeds
19 December 2012
New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
The search for an HIV prevention vaccine

Major Breakthrough in HIV Research: Swiss Vaccine Research Institute

Editor's pick
Business Wire
18 December 2012
HIV treatment for children & young people

DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs

Editor's pick
Eurekalert Inf Dis
12 December 2012
New & experimental HIV treatments

Six Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
11 December 2012